Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 5/20 | 0.38 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 4/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 3/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14125129 | 0.88 | CNR2 (0.36) | PDK2CNR2CNR1 | |
| SCHEMBL25444677 | 0.88 | PDK2 (0.35) | PDK2TLR8PPARD | |
| SCHEMBL15975348 | 0.88 | PDK2 (0.34) | PDK2CNR2CNR1 | |
| SCHEMBL13925431 | 0.87 | PDK2 (0.35) | PDK2TLR8CNR2CNR1 | |
| SCHEMBL15975350 | 0.86 | PDK2 (0.40) | PDK2TLR8CNR2TDP2CNR1 | |
| SCHEMBL13819051 | 0.83 | CNR1 (0.31) | TLR8CNR2CNR1 | |
| SCHEMBL13151896 | 0.83 | CNR2 (0.41) | CNR2CNR1 | |
| SCHEMBL15426047 | 0.82 | CNR1 (0.32) | TLR8CNR2CNR1 | |
| SCHEMBL1108692 | 0.82 | CNR1 (0.32) | TLR8CNR2CNR1 | |
| SCHEMBL16020924 | 0.82 | CNR1 (0.32) | TLR8CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8816334-B2 | N-type materials and organic electronic devices | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-08-26 | — | — | US | disclosed |
| US-20120298976-A1 | N-Type Materials And Organic Electronic Devices | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120298976-A1 | N-Type Materials And Organic Electronic Devices | NANS, DPAGT1, PNN | PDK2 2356/4885TLR8 4501/4885CNR2 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.